Atrial fibrillation in pregnancy: a growing challenge

References

• Jarvis SS, Shibata S, Bivens TB, et al. Sympathetic activation during early pregnancy in humans. Journal Physiol 2012;590(Pt 15):3535-43
   PubMed Web of Science ®Google Scholar
• Brooks VL, Dampney RAL, Heesch CM. Pregnancy and the endocrine regulation of the baroreceptor reflex. Am J Physiol Regulat Integrat Compar Physiol 2010;299:R439-R51
   Google Scholar
• Li J, Umar S, Amjedi M, et al. New frontiers in heart hypertrophy during pregnancy. Am J Cardiovasc Dis 2012;2:192-207
   PubMedGoogle Scholar
• Shotan A, Ostrzega E, Mehra A, et al. Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Cardiol 1997;79:1061-4
   PubMed Web of Science ®Google Scholar
• Rosano GM, Leonardo F, Sarrel PM, et al. Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet 1996;347:786-8
   PubMed Web of Science ®Google Scholar
• Bailey MS, Curtis AB. The effects of hormones on arrhythmias in women. Curr Womens Health Rep 2002;2:83-8
   PubMedGoogle Scholar
• White S, Welch J, Brown LH. The unexpected pitter patter: new-onset atrial fibrillation in pregnancy. Case Rep Emerg Med 2015;2015:4
   Google Scholar
• Gilson GJ, Samaan S, Crawford MH, et al. Changes in hemodynamics, ventricular remodeling, and ventricular contractility during normal pregnancy: a longitudinal study. Obstet Gynecol 1997;89:957-62
   PubMed Web of Science ®Google Scholar
• Silversides CK, Harris L, Haberer K, et al. Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol 2006;97:1206-12
   PubMed Web of Science ®Google Scholar
• Chung E, Leinwand LA. Pregnancy as a cardiac stress model. Cardiovasc Res 2014;101:561-70
   PubMed Web of Science ®Google Scholar
• Castro LC, Hobel CJ, Gornbein J. Plasma levels of atrial natriuretic peptide in normal and hypertensive pregnancies: a meta-analysis. Am J Obstet Gynecol 1994;171:1642-51
   PubMed Web of Science ®Google Scholar
• Clapp JF 3rd, Capeless E. Cardiovascular function before, during, and after the first and subsequent pregnancies. Am J Cardiol 1997;80:1469-73
   PubMed Web of Science ®Google Scholar
• Yosefy C, Shenhav S, Feldman V, et al. Left atrial function during pregnancy: a three-dimensional echocardiographic study. Echocardiography 2012;29:1096-101
   PubMed Web of Science ®Google Scholar
• Sadaniantz A, Kocheril AG, Emaus SP, et al. Cardiovascular changes in pregnancy evaluated by two-dimensional and Doppler echocardiography. J Am Soc Echocardiograp 1992;5:253-8
   PubMedGoogle Scholar
• Grohe C, Kahlert S, Lobbert K, et al. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 1997;416:107-12
   PubMed Web of Science ®Google Scholar
• Goldstein J, Sites CK, Toth MJ. Progesterone stimulates cardiac muscle protein synthesis via receptor-dependent pathway. Fertil Steril 2004;82:430-6
   PubMed Web of Science ®Google Scholar
• Lizotte E, Grandy SA, Tremblay A, et al. Expression, distribution and regulation of sex steroid hormone receptors in mouse heart. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol 2009;23:75-86
   PubMed Web of Science ®Google Scholar
• Zeng T, Bett GC, Sachs F. Stretch-activated whole cell currents in adult rat cardiac myocytes. Am J Physiol Heart Circulat Physiol 2000;278:H548-57
   PubMed Web of Science ®Google Scholar
• Huang H, Liang L, Liu P, et al. Mechanical effects on KATP channel gating in rat ventricular myocytes. PLoS One 2013;8:e63337
   PubMed Web of Science ®Google Scholar
• Takahashi K, Naruse K. Stretch-activated BK channel and heart function. Progress Biophys Molec Biol 2012;110:239-44
   PubMed Web of Science ®Google Scholar
• El Khoury N, Mathieu S, Marger L, et al. Upregulation of the hyperpolarization-activated current increases pacemaker activity of the sinoatrial node and heart rate during pregnancy in mice. Circulation 2013;127:2009-20
   PubMed Web of Science ®Google Scholar
• Eghbali M, Deva R, Alioua A, et al. Molecular and functional signature of heart hypertrophy during pregnancy. Circulat Res 2005;96:1208-16
   PubMed Web of Science ®Google Scholar
• El Gebeily G, El Khoury N, Mathieu S, et al. Estrogen regulation of the transient outward K(+) current involves estrogen receptor alpha in mouse heart. J Molec Cell Cardiol 2015;86:85-94
   PubMed Web of Science ®Google Scholar
• Kundu P, Ciobotaru A, Foroughi S, et al. Hormonal regulation of cardiac KCNE2 gene expression. Molec Cell Endocrinol 2008;292:50-62
   PubMed Web of Science ®Google Scholar
• Gleicher N, Meller J, Sandler RZ, et al. Wolff-Parkinson-White syndrome in pregnancy. Obstet Gynecol 1981;58:748-52
   PubMed Web of Science ®Google Scholar
• Jiang C, Poole-Wilson PA, Sarrel PM, et al. Effect of 17 beta-oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol 1992;106:739-45
   PubMed Web of Science ®Google Scholar
• Chu SH, Goldspink P, Kowalski J, et al. Effect of estrogen on calcium-handling proteins, beta-adrenergic receptors, and function in rat heart. Life Sci 2006;79:1257-67
   PubMed Web of Science ®Google Scholar
• Nakamura H, Kurokawa J, Bai CX, et al. Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study. Circulation 2007;116:2913-22
   PubMed Web of Science ®Google Scholar
• Nakajima T, Iwasawa K, Oonuma H, et al. Antiarrhythmic effect and its underlying ionic mechanism of 17beta-estradiol in cardiac myocytes. Br J Pharmacol 1999;127:429-40
   PubMed Web of Science ®Google Scholar
• Brunet S, Aimond F, Li H, et al. Heterogeneous expression of repolarizing, voltage-gated K + currents in adult mouse ventricles. J Physiol 2004;559(Pt1):103-20
   PubMed Web of Science ®Google Scholar
• Saito T, Ciobotaru A, Bopassa JC, et al. Estrogen contributes to gender differences in mouse ventricular repolarization. Circulat Res 2009;105:343-52
   PubMed Web of Science ®Google Scholar
• Verkerk AO, Wilders R, Veldkamp MW, et al. Gender disparities in cardiac cellular electrophysiology and arrhythmia susceptibility in human failing ventricular myocytes. Int Heart J 2005;46:1105-18
   PubMed Web of Science ®Google Scholar
• Trepanier-Boulay V, St-Michel C, Tremblay A, et al. Gender-based differences in cardiac repolarization in mouse ventricle. Circulat Res 2001;89:437-44
   PubMed Web of Science ®Google Scholar
• Leblanc N, Chartier D, Gosselin H, et al. Age and gender differences in excitation-contraction coupling of the rat ventricle. J Physiol 1998;511(Pt2):533-48
   PubMed Web of Science ®Google Scholar
• Xiao L, Zhang L, Han W, et al. Sex-based transmural differences in cardiac repolarization and ionic-current properties in canine left ventricles. Am J Physiol Heart Circulat Physiol 2006;291:H570-80
   PubMed Web of Science ®Google Scholar
• Gowd BM, Thompson PD. Effect of female sex on cardiac arrhythmias. Cardiol Rev 2012;20:297-303
   PubMed Web of Science ®Google Scholar
• Tanindi A, Akgun N, Pabuccu EG, et al. Electrocardiographic P-wave duration, QT interval, T peak to end interval and Tp-e/QT ratio in pregnancy with respect to trimesters. Ann Noninvas Electrocardiol Offic J Int Soc Holter Noninvas Electrocardiol Inc 2016;21:169-74
   PubMed Web of Science ®Google Scholar
• Altun B, Tasolar H, Gazi E, et al. Atrial electromechanical coupling intervals in pregnant subjects. Cardiovasc J Afr 2014;25:15-20
   PubMed Web of Science ®Google Scholar
• Kirbas O, Biberoglu EH, Kirbas A, et al. P-wave duration changes and dispersion in preeclampsia. Eur J Obstet Gynecol Reproduct Biol 2014;183:141-5
   PubMed Web of Science ®Google Scholar
• Dilaveris PE, Gialafos JE. P-wave dispersion: a novel predictor of paroxysmal atrial fibrillation. Ann Noninvas Electrocardiol Offic J Int Soc Holter Noninvas Electrocardiol Inc 2001;6:159-65
   PubMed Web of Science ®Google Scholar
• Tawam M, Levine J, Mendelson M, et al. Effect of pregnancy on paroxysmal supraventricular tachycardia. Am J Cardiol 1993;72:838-40
   PubMed Web of Science ®Google Scholar
• Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med 1995;98:476-84
   PubMed Web of Science ®Google Scholar
• Lee MS, Chen W, Zhang Z, et al. Atrial fibrillation and atrial flutter in pregnant women-a population-based study. J Am Heart Assoc 2016;5:e003182
   PubMed Web of Science ®Google Scholar
• Salam AM, Ertekin E, van Hagen IM, et al. Atrial fibrillation or flutter during pregnancy in patients with structural heart disease data from the ROPAC (Registry on Pregnancy and Cardiac Disease). JACC Clin Electrophysiol 2015;1:284-92
   PubMedGoogle Scholar
• Sengheiser CJ, Channer KC. Recurrent atrial flutter and fibrillation in pregnancy. BMJ Case Rep 2011;2015:bcr1220103589
   Google Scholar
• Ntusi NB, Badri M, Gumedze F, et al. Pregnancy-associated heart failure: a comparison of clinical presentation and outcome between hypertensive heart failure of pregnancy and idiopathic peripartum cardiomyopathy. PLoS One 2015;10:e0133466
   PubMed Web of Science ®Google Scholar
• Parasuraman R, Gandhi MM, Liversedge NH. Nifedipine tocolysis associated atrial fibrillation responds to DC cardioversion. BJOG Int J Obstet Gynaecol 2006;113:844-5
   PubMed Web of Science ®Google Scholar
• Carson MP, Fisher AJ, Scorza WE. Atrial fibrillation in pregnancy associated with oral terbutaline. Obstetr Gynecol 2002;100:1096-7
   PubMed Web of Science ®Google Scholar
• Michelena HI, Ezekowitz MD. Atrial fibrillation: are there gender differences? JGSM Offic J Partner Women’s Health Columbia 2000;3:44-9
   Google Scholar
• DiCarlo-Meacham A, Dahlke J. Atrial fibrillation in pregnancy. Obstet Gynecol 2011;117:489-92
   PubMed Web of Science ®Google Scholar
• Walsh CA, Manias T, Patient C. Atrial fibrillation in pregnancy. Eur J Obstet Gynecol Reprod Biol 2008;138:119-20
   PubMed Web of Science ®Google Scholar
• Widerhorn J, Bhandari AK, Bughi S, et al. Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy. Am Heart J 1991;122:1162-6
   PubMed Web of Science ®Google Scholar
• Klein V, Repke JT. Supraventricular tachycardia in pregnancy: cardioversion with verapamil. Obstet Gynecol 1984;63(3 Suppl):16s-8s
   PubMed Web of Science ®Google Scholar
• Byerly WG, Hartmann A, Foster DE, et al. Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia. Ann Emerg Med 1991;20:552-4
   PubMed Web of Science ®Google Scholar
• Kleinman CS, Copel JA, Weinstein EM, et al. Treatment of fetal supraventricular tachyarrhythmias. J Clin Ultrasound 1985;13:265-73
   PubMed Web of Science ®Google Scholar
• Lewis G, Currie P. Atrial fibrillation during pregnancy: cardioversion with flecainide. Br J Hosp Med 2015;76:720-1
   PubMed Web of Science ®Google Scholar
• Strizek B, Berg C, Gottschalk I, et al. High-dose flecainide is the most effective treatment of fetal supraventricular tachycardia. Heart Rhythm 2016;13:1283-8
   PubMed Web of Science ®Google Scholar
• Hill LM, Malkasian GD Jr. The use of quinidine sulfate throughout pregnancy. Obstet Gynecol 1979;54:366-8
   PubMed Web of Science ®Google Scholar
• Lydakis C, Lip GY, Beevers M, et al. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 1999;12:541-7
   PubMed Web of Science ®Google Scholar
• Yakoob MY, Bateman BT, Ho E, et al. The risk of congenital malformations associated with exposure to beta-blockers early in pregnancy: a meta-analysis. Hypertension 2013;62:375-81
   PubMed Web of Science ®Google Scholar
• Caton AR, Bell EM, Druschel CM, et al. Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension 2009;54:63-70
   PubMed Web of Science ®Google Scholar
• Rotmensch HH, Elkayam U, Frishman W. Antiarrhythmic drug therapy during pregnancy. Ann Intern Med 1983;98:487-97
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J 2016;50:e1-e88
   Google Scholar
• Hou JW. Fetal warfarin syndrome. Chang Gung Med J 2004;27:691-5
   PubMedGoogle Scholar
• Vitale N, De Feo M, De Santo LS, et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637-41
   PubMed Web of Science ®Google Scholar
• McLintock C. Anticoagulant choices in pregnant women with mechanical heart valves: balancing maternal and fetal risks—the difference the dose makes. Thromb Res 2013;131(Suppl 1):S8-S10
   PubMed Web of Science ®Google Scholar
• Pacheco LD, Saade GR, Costantine MM, et al. Reconsidering the switch from low-molecular-weight heparin to unfractionated heparin during pregnancy. Am J Perinatol 2014;31:655-8
   PubMed Web of Science ®Google Scholar
• Casele HL. The use of unfractionated heparin and low molecular weight heparins in pregnancy. Clin Obstet Gynecol 2006;49:895-905
   PubMed Web of Science ®Google Scholar
• Romualdi E, Dentali F, Rancan E, et al. Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature. J Thromb Haemostas 2013;11:270-81
   PubMed Web of Science ®Google Scholar
• Xu Z, Fan J, Luo X, et al. Anticoagulation regimens during pregnancy in patients with mechanical heart valves: a systematic review and meta-analysis. Can J Cardiol 2015;32:1248.e1?1248.e9
   Web of Science ®Google Scholar
• Tanaka H, Tanaka K, Kamiya C, et al. Analysis of anticoagulant therapy by unfractionated heparin during pregnancy after mechanical valve replacement. Circulat J Offic J Jpn Circulat Soc 2014;78:878-81
   PubMed Web of Science ®Google Scholar
• Cohen H, Arachchillage DR, Middeldorp S, et al. Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH. J Thromb Haemostas 2016;14:1673-6
   PubMed Web of Science ®Google Scholar
• Hoeltzenbein M, Beck E, Meixner K, et al. Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre. Clin Res Cardiol Offic J German Cardiac Soc 2016;105:117-26
   PubMed Web of Science ®Google Scholar
• Beyer-Westendorf J, Michalski F, Tittl L, et al. Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reporting. Thromb Haemostas 2016;116:651-658
   PubMed Web of Science ®Google Scholar